Meropenem (1000mg)

Clinical Pharmacologist's Monograph

⚠️ Prescription Only: This medicine is Schedule H/H1. Do not self-medicate.

1. Clinical Overview

Meropenem is a broad-spectrum, bactericidal carbapenem antibiotic. It is a beta-lactam antibiotic with a structure that confers high stability against most beta-lactamases, including extended-spectrum beta-lactamases (ESBLs). It is a cornerstone of empiric therapy for severe, life-threatening infections in the Indian hospital setting, particularly in ICUs, due to its reliable activity against a wide range of Gram-positive, Gram-negative, and anaerobic bacteria.

OnsetDurationBioavailability
Rapid; bactericidal action begins immediately upon reaching effective tissue concentrations.Approximately 6-8 hours, necessitating dosing every 8 hours for most infections.Not applicable; administered exclusively via intravenous (IV) infusion or bolus injection.

2. Mechanism of Action

Meropenem exerts its bactericidal effect by inhibiting bacterial cell wall synthesis. It has a high affinity for penicillin-binding proteins (PBPs), particularly PBP-2 in Escherichia coli and Pseudomonas aeruginosa, and PBP-1 in Staphylococcus aureus. Binding to these essential enzymes disrupts the final transpeptidation step of peptidoglycan synthesis, leading to osmotic instability and cell lysis.

3. Indications & Uses

  • Complicated intra-abdominal infections (cIAI)
  • Complicated skin and skin structure infections (cSSSI)
  • Bacterial meningitis (in pediatric patients >3 months)
  • Complicated urinary tract infections (cUTI) including pyelonephritis
  • Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP)
  • Empiric therapy for febrile neutropenia

4. Dosage & Administration

Adult Dosage: 1g (1000mg) administered intravenously every 8 hours. For meningitis: 2g every 8 hours.

Administration: For IV infusion: Reconstitute 1g vial with 20 mL Water for Injection. Shake to dissolve. Further dilute in 50-250 mL of compatible IV fluid (0.9% Sodium Chloride or 5% Dextrose). Infuse over 15-30 minutes. For IV bolus: Reconstitute as above and administer over 3-5 minutes (5-20 mL solution). NOT for intramuscular use.

5. Side Effects

Common side effects may include:

  • Diarrhea (including Clostridioides difficile-associated diarrhea)
  • Nausea and vomiting
  • Headache
  • Injection site reactions (pain, inflammation, phlebitis)
  • Rash and pruritus

6. Drug Interactions

DrugEffectSeverity
ProbenecidCompetitively inhibits renal tubular secretion of meropenem, increasing and prolonging meropenem plasma levels. Not recommended for co-administration.Major
Valproic Acid / ValproateMeropenem significantly reduces serum valproic acid levels by up to 60-100%, potentially leading to loss of seizure control. Avoid concomitant use; use alternative antibiotics or monitor valproate levels closely.Major
Other nephrotoxic drugs (e.g., Aminoglycosides, Vancomycin, Loop diuretics)Increased risk of nephrotoxicity. Monitor renal function closely.Moderate
WarfarinPotential for increased anticoagulant effect due to altered gut flora and possible effects on vitamin K. Monitor INR closely.Moderate

7. Patient Counselling

  • Do complete the full course of therapy as prescribed, even if you feel better.
  • Do inform all your doctors about any history of allergies, especially to penicillin or other antibiotics.
  • Do report any severe diarrhea, even if it occurs weeks after finishing the antibiotic.
  • Don't skip doses.
  • Don't use this medicine for colds, flu, or other viral infections.

8. Toxicology & Storage

Overdose: Symptoms may include exaggerated pharmacological effects such as seizures (especially in patients with renal failure), paresthesia, encephalopathy, and neuromuscular excitability. Gastrointestinal effects like nausea and diarrhea may occur.

Storage: Unreconstituted vials: Store below 25°C. Protect from light. Reconstituted Solution: Chemical and physical stability of the reconstituted solution in Water for Injection has been demonstrated for up to 3 hours at up to 25°C. Solutions diluted for infusion in 0.9% Sodium Chloride or 5% Dextrose are stable for up to 4 hours at up to 25°C or 24 hours if stored under refrigeration (2-8°C). Do not freeze. Use immediately after preparation is recommended. Discard any unused portion.